Drug Approval | January 26, 2024
Zydus receives USFDA’s final approval for Gabapentin Tablets, 300 mg and 600 mg
Gabapentin is indicated for the management of Postherpetic Neuraligia
Gabapentin is indicated for the management of Postherpetic Neuraligia
Aarti Drugs has reported total income of Rs. 607.61 crores during the period ended December 31, 2023
Granules India has reported total income of Rs. 1156.23 crores during the period ended December 31, 2023
The receipt of this permission paves way for the launch of Andexanet alfa powder for solution for infusion 200 mg (Andexxa) in India
GMP certification helps enable biotechnology customers to accelerate accessibility of new RNA-based therapies for patients
Glenmark Life Sciences will manufacture API in the therapeutic area of urinary anti-spasmodic, to supply to the global innovator
Pimavanserin is an atypical antipsychotic indicated for the treatment of hallucinations and delusions associated with Parkinson disease psychosis
The Aptivate Champion Run witnessed an enthusiastic participation of over 4,000 Mumbaikars
India’s First Integrated Ayush Wellness Centre to come up in Guwahati, foundation stone laid
Varenicline Tablets (RLD Chantix) had estimated annual sales of US $412 million in the US
Subscribe To Our Newsletter & Stay Updated
